Charles Sternberg, Associate Editor07.12.22
Global contract manufacturer Lincotek has acquired Danco Medical’s facility in Changzhou, Eastern China.
The 15,000 sq ft plant, which is ISO 13485 certified, will further enhance the reputation of the Group’s Medical Division for integrated supply chain solutions and services to the global orthopedic devices industry, delivering best-in-class quality, processes and customer service.
This deal is the culmination of a two-part business transaction, which first saw the Italian company acquire Danco Medical’s 35,000 sq ft facility in Warsaw, Indiana, USA earlier this year. The acquisition of the Changzhou plant was the second and final step in the acquisition of Danco Medical.
Danco Medical offers complete, end-to-end surface preparation and finishing solutions and a wide range of product identification methods to medical orthopedic device companies. Lincotek Medical, meanwhile, is a leader in offering orthopedic device companies fully integrated supply chain solutions, from device conception and manufacturing through to finishing and polishing, and ultimately packaging. The acquisition expands the capabilities of Lincotek in the medical field and boosting service levels.
Winfried Schaller, the CEO of Lincotek Group, said, “It’s great that we have been able to complete the second part of this important transaction, as Danco is recognized as the leader in metal finishing and complements our existing business perfectly. Danco and Lincotek share the same set of values around service, reliability and customer orientation and, with the acquisition of the Changzhou plant, we are now able to provide even more seamless support to our customers globally.”
“Lincotek is a perfect fit for us,” commented Ross Tiamson, CEO of Danco Medical. “We each have our respective strengths, but together we are an even more formidable force in the market. I am looking forward to working closely with colleagues in Lincotek Medical on this new chapter in our corporate history.”
The 15,000 sq ft plant, which is ISO 13485 certified, will further enhance the reputation of the Group’s Medical Division for integrated supply chain solutions and services to the global orthopedic devices industry, delivering best-in-class quality, processes and customer service.
This deal is the culmination of a two-part business transaction, which first saw the Italian company acquire Danco Medical’s 35,000 sq ft facility in Warsaw, Indiana, USA earlier this year. The acquisition of the Changzhou plant was the second and final step in the acquisition of Danco Medical.
Danco Medical offers complete, end-to-end surface preparation and finishing solutions and a wide range of product identification methods to medical orthopedic device companies. Lincotek Medical, meanwhile, is a leader in offering orthopedic device companies fully integrated supply chain solutions, from device conception and manufacturing through to finishing and polishing, and ultimately packaging. The acquisition expands the capabilities of Lincotek in the medical field and boosting service levels.
Winfried Schaller, the CEO of Lincotek Group, said, “It’s great that we have been able to complete the second part of this important transaction, as Danco is recognized as the leader in metal finishing and complements our existing business perfectly. Danco and Lincotek share the same set of values around service, reliability and customer orientation and, with the acquisition of the Changzhou plant, we are now able to provide even more seamless support to our customers globally.”
“Lincotek is a perfect fit for us,” commented Ross Tiamson, CEO of Danco Medical. “We each have our respective strengths, but together we are an even more formidable force in the market. I am looking forward to working closely with colleagues in Lincotek Medical on this new chapter in our corporate history.”